Kratom: Responsible Use, Legality & What to Know

Kratom (Mitragyna speciosa) is a botanical with a complex profile — a long history of traditional use in Southeast Asia, a growing body of Western research, significant regulatory attention, and a market with serious quality control problems. This page is written for adults who want accurate information before making a decision about kratom use.

We sell kratom. We also believe that informed consumers make better decisions than uninformed ones. This page does not minimize kratom's risks or overstate its benefits.

What Is Kratom?

Kratom is a tropical tree (Mitragyna speciosa) native to Southeast Asia, particularly Indonesia, Thailand, Malaysia, and Papua New Guinea. Its leaves contain over 40 alkaloids, with mitragynine and 7-hydroxymitragynine being the primary active compounds. These alkaloids interact with opioid receptors in the brain — a fact that is central to both kratom's effects and its regulatory status.

In its native regions, kratom leaves have been chewed or brewed as tea by agricultural workers for centuries, primarily as a stimulant to manage fatigue during long workdays. At low doses, it produces stimulant-like effects. At higher doses, it produces opioid-like sedation and analgesia.

Effects by Dose

Kratom's effects are strongly dose-dependent:

  • Low doses (1–5g of dried leaf powder): Increased energy, alertness, sociability, reduced fatigue. Effects are stimulant-like and typically last 1–2 hours.
  • Moderate doses (5–10g): Transition zone — effects shift toward sedation, analgesia, and euphoria. Duration extends to 3–5 hours.
  • High doses (10g+): Strong opioid-like sedation, analgesia, nausea, and dizziness are common. Not recommended, particularly for new users.

Individual response varies significantly based on body weight, tolerance, and the specific alkaloid profile of the product. Start with the lowest effective dose and adjust slowly.

Vein Color Guide

Vein color refers to the color of the central vein of the kratom leaf at harvest. It reflects leaf maturity and affects the alkaloid ratio:

  • White vein: Harvested from younger leaves. Higher mitragynine relative to 7-hydroxymitragynine. Effects tend toward stimulation, energy, and focus. Less sedating.
  • Green vein: Harvested at intermediate maturity. Balanced alkaloid profile. Effects are intermediate — moderate energy with some relaxation. Often described as the most versatile.
  • Red vein: Harvested from mature leaves. Higher 7-hydroxymitragynine relative to mitragynine. Effects tend toward relaxation, sedation, and discomfort relief. More sedating.

Strain names (Maeng Da, Malay, Sumatra, Borneo, Indo) refer to the geographic origin or a specific cultivar. They affect the overall alkaloid profile and potency in addition to vein color.

Risks and Safety Considerations

Physical Dependence

Regular, high-dose kratom use can produce physical dependence. Withdrawal symptoms upon cessation include muscle aches, insomnia, irritability, nausea, sweating, and anxiety. The severity is generally proportional to dose and duration of use. Withdrawal is rarely medically dangerous but can be uncomfortable. Tapering the dose gradually rather than stopping abruptly reduces withdrawal severity.

Tolerance

Tolerance to kratom's effects develops with regular use. To minimize tolerance, avoid daily use, rotate strains, and take regular breaks ("tolerance breaks" of 1–2 weeks).

Drug Interactions

Kratom is metabolized by the liver enzyme CYP3A4. Drugs that inhibit or induce CYP3A4 can significantly alter kratom's effects and duration. Do not combine kratom with: opioids or opioid medications (additive CNS depression risk), benzodiazepines or other sedatives, MAO inhibitors (serious interaction risk), or alcohol. If you take any prescription medications, consult a healthcare provider before using kratom.

Liver Toxicity

Rare cases of kratom-associated liver injury have been reported in the medical literature. The mechanism is not fully understood and may involve adulterants in low-quality products rather than kratom alkaloids themselves. If you experience jaundice, dark urine, or abdominal pain while using kratom, discontinue use and seek medical attention.

Not for Certain Populations

Kratom is not appropriate for: individuals under 18, pregnant or breastfeeding individuals, individuals with liver disease, individuals with a history of opioid use disorder (without medical supervision), or individuals taking medications with known CYP3A4 interactions.

Legal Status

Kratom is not scheduled under the US federal Controlled Substances Act as of the date of this writing. However, its legal status varies by state and locality:

States where kratom is banned or restricted: Alabama, Arkansas, Indiana, Rhode Island, Vermont, Wisconsin. Additionally, some counties and municipalities in other states have local restrictions. Always verify the current legal status in your specific jurisdiction before purchasing. Laws change — this information may not reflect the most current status.

The FDA has not approved kratom for any medical use and has issued import alerts and warning letters to kratom companies making unsubstantiated health claims. We do not make medical claims about kratom.

Quality and Adulteration

The kratom market has a documented adulteration problem. Products have been found to contain undisclosed synthetic opioids, heavy metals from poor agricultural practices, and microbial contamination from improper processing. This is not a minor issue — adulterated kratom has been linked to serious adverse events.

At Herb Dr, our kratom is:

  • Sourced directly from verified suppliers in Indonesia (Borneo and Sumatra)
  • Dried and milled leaf only — no enhanced extracts with undisclosed alkaloid concentrations
  • Tested for heavy metals (lead, mercury, arsenic, cadmium) against California Prop 65 limits
  • Tested for microbial contamination
  • Not spiked with synthetic compounds

We make COAs available on request for any batch. See our Third-Party Testing & COA Policy for details.

Responsible Use Guidelines

  • Start with the lowest effective dose (1–2g) and increase slowly
  • Do not use daily — limit use to 2–3 times per week to minimize tolerance and dependence risk
  • Do not combine with other CNS depressants (opioids, benzodiazepines, alcohol)
  • Take regular breaks from use
  • Do not drive or operate machinery when using kratom at moderate or high doses
  • Keep out of reach of children
  • If you develop signs of dependence, seek support from a healthcare provider

This page is for informational purposes only. Kratom has not been evaluated by the FDA for safety or efficacy. It is not intended to diagnose, treat, cure, or prevent any disease. This information does not constitute medical advice.